Enskyce
Product Images NDC 68180-891

7 FDA label images from Lupin Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Enskyce (NDC 68180-891). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

0df0b7c1 F980 49d0 B282 99c93fb7dcbd 01

0df0b7c1 F980 49d0 B282 99c93fb7dcbd 01
Chemical structure diagram showing the molecules desogestrel and ethinyl estradiol, which are active ingredients in the product ENSKYCE by Lupin Pharmaceuticals, Inc.*
FDA Label Image

0df0b7c1 F980 49d0 B282 99c93fb7dcbd 02

0df0b7c1 F980 49d0 B282 99c93fb7dcbd 02
A bar chart displaying mortality rate (number of deaths per 100,000 woman-years) across four age groups (15-24, 25-34, 35-44, 45-) for four categories: ever-users (non-smokers), controls (non-smokers), ever-users (smokers), and controls (smokers). Mortality rates increase with age, with ever-users who are smokers consistently showing the highest rates across all age groups.*
FDA Label Image

0df0b7c1 F980 49d0 B282 99c93fb7dcbd 03

0df0b7c1 F980 49d0 B282 99c93fb7dcbd 03
A forest plot chart depicting effect estimates (odds ratios/relative risks) with 95% confidence intervals from several studies on contraceptive use. The studies listed include NICHD Women's Contraceptive Study (2002), French E3N Cohort (2005), Shangai Women's Health Study (2009), Nurses' Health Study II (2010), Oxford Family Planning Association (2013), and Danish Sex Hormone Register Study (2017). Each effect estimate is plotted along a horizontal axis representing values from -1.5 to 2, showing comparisons of ever use and current use estimates with markers and confidence interval bars.*
FDA Label Image

0df0b7c1 F980 49d0 B282 99c93fb7dcbd 04

0df0b7c1 F980 49d0 B282 99c93fb7dcbd 04
An instructional diagram showing a 28-day pill pack layout for ENSKYCE with days of the week labeled from Sunday to Saturday in four rows representing weeks 1 to 4. The diagram includes arrows indicating the direction to follow daily pill intake, and instructions for day-1 starters explaining how to align the day label strip if the period starts on a day other than Sunday. A note on the right reminds users about monthly self breast exams.*
FDA Label Image

0df0b7c1 F980 49d0 B282 99c93fb7dcbd 05

0df0b7c1 F980 49d0 B282 99c93fb7dcbd 05
Blister pack label and foil for Enskyce, desogestrel and ethinyl estradiol tablets USP 0.15 mg / 0.03 mg by Lupin Pharmaceuticals, Inc. The lidding foil side includes the product name, strength, storage instructions, distribution and manufacturing information, and a barcode. The forming foil/PVC side shows a 4-week calendar layout for daily pill administration with arrows indicating the order, starting Sunday, and a note for monthly self breast exam.*
FDA Label Image

0df0b7c1 F980 49d0 B282 99c93fb7dcbd 06

0df0b7c1 F980 49d0 B282 99c93fb7dcbd 06
Packaging label for Enskyce tablets, containing desogestrel and ethinyl estradiol USP 0.15 mg/0.03 mg. The product is distributed by Lupin Pharmaceuticals, Inc. and contains one blister pack of 28 tablets. The label includes dosage information, storage instructions, warnings about HIV protection, and a statement that it is for prescription use only.*
FDA Label Image

0df0b7c1 F980 49d0 B282 99c93fb7dcbd 07

0df0b7c1 F980 49d0 B282 99c93fb7dcbd 07
Packaging label for Enskyce 0.15 mg/0.03 mg tablets, containing desogestrel and ethinyl estradiol tablets USP. The label indicates Rx only and shows 3 blisters of 28 tablets each. Distributed by Lupin Pharmaceuticals, Inc., Baltimore, Maryland, and manufactured by Lupin Limited, India. The box includes a barcode and Lupin's logo with the tagline "Enhancing Women's Care."*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.